Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Corpechot

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Journal of Autoimmunity|February 8, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trialRoberta Lorenzon, Claire Ribet, Fabien Pitoiset, et al.
Clinics and Research in Hepatology and Gastroenterology|July 31, 2021
Non-invasive diagnosis and follow-up in liver transplantationJérôme Dumortier, Camille Besch, Lucile Moga, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR studyMaria C van Hooff, Rozanne C de Veer, Vincent Karam, et al.
Medicine|July 30, 2015
Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 CasesMaxime Dauvergne, Anissa Moktefi, Marion Rabant, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratificationAlessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.
The American Journal of Gastroenterology|June 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study ResultsCynthia Levy, Palak J Trivedi, Kris V Kowdley, et al.
Journal of Hepatology|April 14, 2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H Harms, Henk R van Buuren, Christophe Corpechot, et al.
Annals of the Rheumatic Diseases|November 26, 2018
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trialMichelle Rosenzwajg, Roberta Lorenzon, Patrice Cacoub, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Journal of Autoimmunity|February 8, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trialRoberta Lorenzon, Claire Ribet, Fabien Pitoiset, et al.
Clinics and Research in Hepatology and Gastroenterology|July 31, 2021
Non-invasive diagnosis and follow-up in liver transplantationJérôme Dumortier, Camille Besch, Lucile Moga, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR studyMaria C van Hooff, Rozanne C de Veer, Vincent Karam, et al.
Medicine|July 30, 2015
Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 CasesMaxime Dauvergne, Anissa Moktefi, Marion Rabant, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratificationAlessio Gerussi, Damiano Verda, Davide Paolo Bernasconi, et al.
The American Journal of Gastroenterology|June 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study ResultsCynthia Levy, Palak J Trivedi, Kris V Kowdley, et al.
Journal of Hepatology|April 14, 2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H Harms, Henk R van Buuren, Christophe Corpechot, et al.
Annals of the Rheumatic Diseases|November 26, 2018
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trialMichelle Rosenzwajg, Roberta Lorenzon, Patrice Cacoub, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
Pageof 12